Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GM1 ganglioside (monosialotetrahexosylganglioside) is a glycosphingolipid found in the outer leaflet of plasma membranes, especially abundant in neuronal tissues but also present on mucosal epithelial cells. It serves as a key receptor for certain bacterial toxins and viruses, notably cholera toxin and Escherichia coli heat-labile enterotoxin. Within membrane rafts, GM1 participates in signaling pathways by associating with proteins such as G protein-coupled receptors, modulates ion transporters, and influences neuronal excitability. Antibodies against GM1 are implicated in disorders such as Guillain–Barré syndrome and multifocal motor neuropathy.
N/A
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GM1 Ganglioside (GM1).